Alkermes plc
ALKS
$28.40
$1.204.41%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/17/2026
-
MarketBeat
3/17/2026
-
MarketBeat
3/15/2026
-
MarketBeat
3/15/2026
-
MarketBeat
3/14/2026
-
MarketBeat
3/12/2026
-
MarketBeat
3/12/2026
-
Business Wire
3/12/2026
-
Simply Wall St
3/11/2026
-
Zacks Investment Research
3/10/2026
-
Business Wire
3/9/2026
-
Nasdaq News: Markets
3/9/2026
-
MarketBeat
3/9/2026
-
Simply Wall St
3/8/2026
-
MarketBeat
3/7/2026
-
Simply Wall St
3/6/2026
-
TipRanks Financial Blog
3/6/2026
-
MarketBeat
3/5/2026
-
MarketBeat
3/5/2026
-
MarketBeat
3/5/2026
-
Ticker Report
3/5/2026
-
Ticker Report
3/5/2026
-
MarketBeat
3/5/2026
-
MarketBeat
3/3/2026
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 25, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
353 1 772 8000
Address
Connaught House
1 Burlington Road - Dublin 4
Dublin, D04 C5Y6
1 Burlington Road - Dublin 4
Dublin, D04 C5Y6
Country
Year Founded
Business Description
Sector
--
Industry
--
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas...
more